Doctors do still check the prostate with a finger, but the exam’s role has shifted considerably over the past two decades. The digital rectal examination, or DRE, was once a cornerstone of routine prostate cancer screening for men over 50. Today, major guidelines no longer recommend it as a standalone screening tool, and many primary care physicians have stopped performing it during annual checkups. Yet urologists, emergency physicians, and other specialists continue to rely on the DRE for a range of clinical situations that go well beyond cancer detection.
Why the DRE Lost Its Place in Routine Screening
The biggest reason you’re less likely to get a finger exam at your yearly physical is a formal recommendation from the U.S. Preventive Services Task Force. In its 2018 guidance on prostate cancer screening, the Task Force stated plainly that the digital rectal examination “is not recommended because there is a lack of evidence on the benefits,” noting that the DRE was either eliminated from or never included in the major randomized screening trials that shaped current policy.1U.S. Preventive Services Task Force. Prostate Cancer: Screening Without solid trial data showing that routine DRE actually reduces deaths from prostate cancer, the Task Force couldn’t justify recommending it for asymptomatic men.
That recommendation carried enormous weight. Primary care doctors, internists, and family physicians tend to follow Task Force guidelines closely, since these recommendations often determine what insurance will cover and what counts as standard-of-care practice. The result has been a quiet but dramatic decline in how often the exam gets performed in general practice settings. A study at a South African academic hospital found that only about 13% of non-urologist physicians were performing DREs, whether alone or combined with a PSA blood test.2PubMed. A finger or not? Prostate examinations by non-urologists at a South African academic institution While that figure comes from a single institution, it reflects a broader trend seen in surveys from multiple countries: the DRE is becoming less common in everyday clinical practice outside urology offices.
How Accurate Is the Finger Exam, Really?
The DRE’s accuracy for detecting prostate cancer is, frankly, mediocre compared to what most people assume. A systematic review and meta-analysis comparing the DRE to the PSA blood test found that PSA had significantly higher sensitivity and specificity for detecting prostate cancer.3African Journal of Urology. Clinical diagnosis of prostate cancer using digital rectal examination and prostate-specific antigen tests: a systematic review and meta-analysis of sensitivity and specificity In plainer terms, the blood test is better at both catching cancers that are there and avoiding false alarms when cancer isn’t present.
Individual studies paint a more detailed picture. One analysis at a teaching hospital found DRE sensitivity of about 68% and specificity of roughly 84%, with a negative predictive value around 87%.4Ibom Medical Journal. Sensitivity and Specificity of Digital Rectal Examination for the Diagnosis of Prostate Cancer at the Kano Teaching Hospital – A Comparative Analysis That means a normal-feeling exam misses roughly a third of cancers, and about one in six abnormal findings turns out to be a false alarm. Those numbers aren’t terrible for a quick bedside test that costs nothing and requires no lab work, but they aren’t reassuring enough to build a screening program around.
The deeper problem is consistency. A large randomized screening trial examined how different examiners interpreted the same test and found staggering variation. The rate at which different doctors called a DRE “suspicious” ranged from 4% to 28% of patients, even in the same study population. Some examiners were statistically three to four times more likely to call an exam abnormal than their colleagues.5PubMed. The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer Reassuringly, an abnormal DRE did predict a higher chance of finding cancer regardless of who performed it, but the wildly different thresholds for calling something abnormal mean your result depends partly on which doctor’s finger you get. That kind of variability undermines the exam’s usefulness as a population-level screening tool.
Where the DRE Still Gets Used
Dropping the DRE from routine cancer screening doesn’t mean the exam has disappeared from medicine. Urologists and other specialists still perform it frequently, and for good reason. The exam provides tactile information that no blood test or imaging study quite replicates. A narrative review in Cureus described the DRE as providing a hands-on assessment of prostate dimensions, texture, and consistency that helps clinicians differentiate between benign enlargement, inflammation, and possible malignancy.6PubMed Central. Clinical Reliability and Diagnostic Value of Digital Rectal Examination in the Detection of Prostate Cancer and Broader Clinical Practice: A Narrative Review
The situations where a DRE remains standard practice include:
- Urinary symptoms: If you’re having trouble urinating, experiencing a weak stream, or getting up multiple times a night, a DRE can give your doctor a quick sense of whether your prostate feels enlarged, boggy from inflammation, or unusually firm.
- Elevated PSA: When a blood test comes back high, many urologists perform a DRE to gather additional information before deciding whether to proceed to imaging or biopsy.
- Active surveillance: Men who have been diagnosed with low-risk prostate cancer and are being monitored rather than treated often get periodic DREs as part of their ongoing follow-up.
- Acute prostatitis: When infection is suspected, the exam can reveal a tender, swollen gland that helps confirm the diagnosis and guide antibiotic treatment.
In other words, the DRE has shifted from a screening tool aimed at healthy men with no symptoms to a diagnostic and monitoring tool used when there’s already a clinical reason to examine the prostate. That distinction matters: screening means testing people who feel fine, while diagnostic testing means investigating a symptom or an abnormal result. The DRE is much more defensible in the second role.
Estimating Prostate Size by Touch
One of the DRE’s longstanding jobs has been estimating how big the prostate is, which helps guide treatment decisions for conditions like benign prostatic hyperplasia (BPH), the non-cancerous enlargement that causes urinary trouble in many older men. The accuracy of this estimate turns out to be limited but not useless.
A study comparing DRE estimates to ultrasound measurements found only moderate correlation between the two. The median prostate volume measured by ultrasound was 53 mL, while the DRE-based estimate came in at 40 mL, and the statistical correlation was modest.7PubMed Central. Why I Cannot Find the Prostate? Behind the Subjectivity of Rectal Exam That same study concluded that the DRE isn’t a reliable predictor of actual prostate volume, though it can help distinguish small glands from large ones.
A broader systematic review covering nearly 8,000 patients across 19 studies reached a similar conclusion. Most studies reported correlation coefficients between DRE estimates and measured volumes in the range of 0.3 to 0.7, which is weak to moderate. However, when the question was simplified to “Is this prostate enlarged or not?” rather than “How many milliliters is it?”, concordance was generally high.8Journal of Clinical Urology. A systematic review of the accuracy of the digital rectal examination as a method of measuring prostate gland volume The practical takeaway is that a DRE can tell your doctor “yes, this gland is bigger than expected” but shouldn’t be relied on for precise sizing. When exact measurements matter, like for planning surgery or choosing between medications, imaging is the better tool.
The DRE in Emergency and Trauma Settings
If you’ve ever been to an emergency room after an injury, you may have experienced a rectal exam as part of the trauma evaluation. For decades, the DRE was considered mandatory in trauma assessments to check for spinal cord injury (by testing sphincter tone), urethral disruption (by feeling for a displaced prostate), and bowel injury (by looking for blood in the rectum). But evidence has challenged this practice too.
A study of more than 400 trauma patients found that the prostate exam was normal in over 99% of cases, with no high-riding or non-palpable prostate glands detected. Occult blood was found in about 5% of patients, but in none of those cases did that finding actually change initial management. The DRE influenced treatment decisions in only about 1% of all trauma patients, and those were all penetrating injuries to the perineal area where gross blood prompted surgical exploration.9PubMed. Digital rectal examination for trauma: does every patient need one? Many trauma centers have since moved away from routine DRE in all injured patients, reserving it for cases where the mechanism of injury specifically raises concern about pelvic or rectal damage.
Why Many Men Avoid or Dread the Exam
The DRE carries cultural and psychological weight that goes beyond the physical discomfort of the exam itself. A systematic review of 60 qualitative studies involving more than 3,000 men across eight countries explored men’s perspectives on prostate cancer screening and identified “preserving masculinity” as a major theme. Within that theme, the DRE was described in terms of bodily invasion, threats to perceived manhood, and fears about sexuality. These feelings contributed to medical avoidance and delayed screening in many of the men studied.10PubMed Central. Men’s perspectives of prostate cancer screening: A systematic review of qualitative studies
The physical discomfort is real but usually brief. For most men, the exam takes less than a minute and produces pressure or mild discomfort rather than pain. Men with hemorrhoids, anal fissures, or conditions affecting the pelvic floor may find it more uncomfortable. What the research suggests, though, is that the psychological barrier often looms larger than the physical one. Some men delay all prostate-related care because they associate it with the DRE, even when the visit might only involve a blood draw for PSA.
The shift away from routine DRE screening has had an unintended positive side effect: men who were avoiding the doctor entirely because of the finger exam may now be more willing to discuss prostate health, since the conversation is more likely to start with a blood test than a physical exam.
A Training Problem Behind the Scenes
One underappreciated factor in the DRE’s inconsistency is how poorly doctors are trained to perform it. Research on medical students and newly graduated doctors has found that many feel insufficiently prepared for the exam. Final-year students specifically reported that lack of supervision was the most significant barrier to developing DRE skills, and even when junior doctors performed the exam in clinical settings, they often weren’t adequately supervised by senior physicians.11PubMed Central. Digital rectal examination skills: first training experiences, the motives and attitudes of standardized patients
This creates a self-reinforcing cycle. If young doctors aren’t confident performing DREs, they avoid doing them. If they avoid doing them, they never get better at it. If they’re never good at it, the exam’s reliability suffers, which gives guideline committees less reason to recommend it, which further reduces training opportunities. The interobserver variability data from the screening trial mentioned earlier partly reflects this problem: the wide gap between examiners who flagged 4% versus 28% of prostates as suspicious isn’t just about different clinical thresholds. It’s also about different levels of skill and experience with a technique that gets less practice time than it used to.
Consent and the Intimate Exam
The DRE is classified as an intimate examination, alongside pelvic exams and breast exams, meaning it involves areas of the body associated with privacy and vulnerability. There has been growing attention in recent years to how consent is handled for such procedures, particularly when they’re performed on patients who are sedated or under anesthesia for other reasons.
A review in HEC Forum documented escalating opposition to performing intimate exams without explicit patient consent, including legislative bans in some jurisdictions and whistleblower reports from medical institutions. The authors argued that because patients are the rights-holders of their own bodies, consent practices should reflect and uphold patient values, which call for explicit consent before any intimate exam.12PubMed Central. A Pot Ignored Boils On: Sustained Calls for Explicit Consent of Intimate Medical Exams
In practical terms, this means you should expect your doctor to explain why a DRE is being recommended, what they’re looking for, and to ask for your agreement before proceeding. If you’re seeing a urologist for symptoms and a DRE is part of the workup, it should be a conversation, not a surprise. If you’re uncomfortable, you can ask about alternatives such as imaging or whether the exam can be deferred. A good clinician will respect that discussion rather than insisting the exam is non-negotiable.
What Might Replace the Finger Exam
The decline of the screening DRE hasn’t left a vacuum. Multiparametric MRI of the prostate has become increasingly central to prostate cancer diagnosis, offering detailed imaging that can identify suspicious areas before a biopsy needle goes anywhere near the gland. Blood-based and urine-based biomarkers are also evolving beyond the traditional PSA test. Newer tests can assess specific genetic markers or protein signatures that help distinguish aggressive cancers from slow-growing ones that may never need treatment.
None of these technologies have fully replaced the DRE for every clinical scenario, though. An MRI can show you a lesion’s size and location, but it can’t tell the clinician whether the gland feels boggy and tender (suggesting infection) or rock-hard and irregular (suggesting cancer). Biomarker panels are promising but still work best when combined with other clinical information. For urologists managing patients with known prostate disease, the DRE remains a quick, free, and immediately available source of information that complements more expensive and time-consuming tests.
The honest assessment is that the DRE is unlikely to return to its former status as something every man over 50 gets at every annual checkup. But it’s equally unlikely to vanish from clinical medicine. Its future is probably as a targeted exam performed by specialists for specific indications, not as a routine screen performed by primary care doctors on healthy men. If your doctor reaches for a glove and tells you they need to check your prostate, it almost certainly means they have a clinical reason for doing so, and the information they gather will actually inform your care.